Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-Effect Study of Mitapivat in Healthy Subjects
NCT04472832Phase 1Completed
- Sponsor
- Agios Pharmaceuticals
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of mitapivat in pyruvate kinase deficiency (PKD) (4 arms), sponsored by Agios Pharmaceuticals. Primary endpoints: Area Under the Plasma Concentration Versus Time Curve From Time 0 to the Last Quantifiable Concentration, Area Under the Curve From Time 0 Extrapolated to Infinity and 6 more. Started Jun 2020; status: completed.
02
Drugs
mitapivat
03
Conditions
pyruvate kinase deficiency (PKD)
Beyond the preview
Go deeper on NCT04472832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04472832.